ES2052583T3 - Derivados de peptidos relacionados con el gel calcitonina. - Google Patents

Derivados de peptidos relacionados con el gel calcitonina.

Info

Publication number
ES2052583T3
ES2052583T3 ES87310695T ES87310695T ES2052583T3 ES 2052583 T3 ES2052583 T3 ES 2052583T3 ES 87310695 T ES87310695 T ES 87310695T ES 87310695 T ES87310695 T ES 87310695T ES 2052583 T3 ES2052583 T3 ES 2052583T3
Authority
ES
Spain
Prior art keywords
derivatives
peptides related
serum
calcium
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87310695T
Other languages
English (en)
Inventor
Kaoru Morita
Toyonobu Uzawa
Masayuki Hori
Toshiharu Noda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Application granted granted Critical
Publication of ES2052583T3 publication Critical patent/ES2052583T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57527—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN PEPTIDO DE FORMULA (1), EN LA QUE Y ES AZUFRE O METILENO Y A ES ASN O ASP, O UNA DE SUS SALES FISIOLOGICAMENTE ACEPTABLES; TIENE ACTIVIDAD DE DSIMINUCION DEL CALCIO EN EL SUERO Y ACTIVIDAD DE DISMINUCION DE FOSFATO EN EL SUERO, Y POR ELLO SE PUEDE UTILIZAR EN EL TRATAMIENTO DE DESORDENES METABOLICOS DE CALCIO, ENFERMEDADES CARDIACAS Y ULCERAS POR MEJORA DEL SISTEMA CIRCULATORIO DEL CEREBRO.
ES87310695T 1986-12-04 1987-12-04 Derivados de peptidos relacionados con el gel calcitonina. Expired - Lifetime ES2052583T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28959786 1986-12-04
JP31058586 1986-12-25

Publications (1)

Publication Number Publication Date
ES2052583T3 true ES2052583T3 (es) 1994-07-16

Family

ID=26557652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87310695T Expired - Lifetime ES2052583T3 (es) 1986-12-04 1987-12-04 Derivados de peptidos relacionados con el gel calcitonina.

Country Status (4)

Country Link
US (1) US5049654A (es)
EP (1) EP0270376B1 (es)
DE (1) DE3782010T2 (es)
ES (1) ES2052583T3 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
ATE128359T1 (de) * 1988-01-11 1995-10-15 Amylin Pharmaceuticals Inc Behandlung von diabetes mellitus typ 2.
US5175145A (en) * 1988-08-26 1992-12-29 Amylin Pharmaceuticals, Inc. Treatment of diabetes mellitus with amylin agonists
GB8829432D0 (en) * 1988-12-15 1989-02-01 Celltech Ltd Enzymatic process
EP0408294B1 (en) * 1989-07-10 1995-09-20 Amylin Pharmaceuticals, Inc. Use of an amylin antagonist for the manufacture of amedicament for the treatment of obesity and essential hypertension and related disorders
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5567679A (en) * 1993-12-13 1996-10-22 Daly; Theodore J. Use of CGRP in treating alopecia
US6211244B1 (en) 1994-10-21 2001-04-03 Nps Pharmaceuticals, Inc. Calcium receptor-active compounds
EP0907631B1 (en) 1996-05-01 2003-06-18 Nps Pharmaceuticals, Inc. Inorganic ion receptor-active compounds
HUP0101629A2 (en) * 1998-04-15 2003-03-28 Aventis Pharma Inc Process for the preparation of resin-bound cyclic peptides
CA2292902C (en) * 1999-12-24 2012-12-18 Alain Cadieux Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases
EP1856126A2 (en) 2005-02-17 2007-11-21 Wyeth a Corporation of the State of Delaware Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514331A (en) * 1983-06-29 1985-04-30 University Patents, Inc. Peptide hormones with calcitonin-like activity
JPS62129297A (ja) * 1985-08-09 1987-06-11 Toyo Jozo Co Ltd カルシトニン遺伝子関連ペプチド誘導体

Also Published As

Publication number Publication date
DE3782010T2 (de) 1993-02-18
EP0270376A2 (en) 1988-06-08
EP0270376A3 (en) 1990-02-07
EP0270376B1 (en) 1992-09-30
DE3782010D1 (de) 1992-11-05
US5049654A (en) 1991-09-17

Similar Documents

Publication Publication Date Title
ES2052583T3 (es) Derivados de peptidos relacionados con el gel calcitonina.
ATE113208T1 (de) Verwendung des wirkstoffs azelastin zur bekämpfung von psoriasis-erkrankungen.
ATE308336T1 (de) Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten
MX9203543A (es) Medicamento.
DK215287D0 (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
RU95106651A (ru) Аналоги дзе-тур динорфина и способ лечения толерантных состояний у пациента
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
IT8619055A0 (it) Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli statidi shock e dell'insufficienza respiratoria e cardiocircolatoria.
ES2061823T3 (es) Nueva proteina h que es capaz de fijarse a igg, gen que codifica dicha proteina h, y un procedimiento para producir dicha proteina h.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
BR9007115A (pt) Novo trombolitico
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
PT85454A (de) Verwendung von 15-deoxyspergualin als arzneimittel
ATA188385A (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
DE3751602D1 (de) Subkutane Verabreichung des humanen Choriongonadotropins.
NO167144C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv imidazo (4,5-f) isokinolin-2-on.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
IT8720291A0 (it) Sintesi di alfa amminoacidi otticamente attivi.
NO161494C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner.
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
DK301489D0 (da) Cgrp til anvendelse til forbedring cerebral blodtilfoersel
IT8419940A0 (it) Nuovi medicinali per il trattamento di malattie cardiache.
DE3851669D1 (de) Verwendung von Gepiron für Medikamente zur Milderung panischer Zustände.
DE3687448D1 (de) Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 270376

Country of ref document: ES